Cargando…
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody
CTLA-4 and CD28 exemplify a co-inhibitory and co-stimulatory signaling axis that dynamically sculpts the interaction of antigen-specific T cells with antigen-presenting cells. Anti-CTLA-4 antibodies enhance tumor-specific immunity through a variety of mechanisms including: blockade of CD80 or CD86 b...
Autores principales: | Gombos, Randi B., Gonzalez, Ana, Manrique, Mariana, Chand, Dhan, Savitsky, David, Morin, Benjamin, Breous-Nystrom, Ekaterina, Dupont, Christopher, Ward, Rebecca A., Mundt, Cornelia, Duckless, Benjamin, Tang, Hao, Findeis, Mark A., Schuster, Andrea, Waight, Jeremy D., Underwood, Dennis, Clarke, Christopher, Ritter, Gerd, Merghoub, Taha, Schaer, David, Wolchok, Jedd D., van Dijk, Marc, Buell, Jennifer S., Cuillerot, Jean-Marie, Stein, Robert, Drouin, Elise E., Wilson, Nicholas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884502/ https://www.ncbi.nlm.nih.gov/pubmed/29617360 http://dx.doi.org/10.1371/journal.pone.0191926 |
Ejemplares similares
-
New tricks for old targets: Anti-CTLA-4 antibodies re-envisioned for cancer immunotherapy
por: Waight, Jeremy D., et al.
Publicado: (2018) -
Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013) -
Immunotherapy and the belly of the beast
por: Merghoub, Taha, et al.
Publicado: (2014) -
PncAgene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis
por: Untiveros, Katherine Lozano, et al.
Publicado: (2014) -
CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
por: Callahan, Margaret K., et al.
Publicado: (2015)